It is an experimental procedure, that can bring great results but, unfortunately, only after a long period of time and in very few cases.
At the moment, the most promising project is the one called ARGUS II Retinal Implant, by the american company Second Sight. It has been used also for treating end-stage pigmented retinopathy, with some successful cases.
One of the retinopathy centers to be considered for this device is the Philadelphia Wills Eye Institute, where Dr. Badalà worked. He now works as an ophthalmologist in Milan and Catania and has experience on the device.
Giuseppe Grasso, Catania
Votazione: EccellenteAfter having consulted several doctors, last year I turned to Dr. Badalà because I felt a discomfort to the eye. At first sight Dr. Badalà realized that there was something wrong in my right eye and, after a thorough e... Keep on reading this reviewxamination and an OCT, he confirmed the presence of a hole in the retina (which no other doctor had seen before) and he suggested me a vitrectomy.
After consulting other doctors who, despite having confirmed the diagnosis, suggested me to wait, I decided to entrust Dr. Badalà, because he inspired me with confidence during the visit.
I had a vitrectomy under local anesthesia about five months ago. The surgery was good and my eyesight has improved and I no longer see distorted images.
The thing that struck me most is that at first I was so used to don’t see well that I didn’t realize it, so much so that I had turned to Dr. Badalà just for a burning sensation to the eye. Thanks to the professionalism and accuracy of Dr. Badalà today I realize I see much better.